This report highlights the global impact of research conducted by Scotland’s five medical schools. Drawing on 17 case studies submitted to the 2014 Research Excellence Framework (REF), it showcases how Scottish medical research has improved health outcomes, influenced policy and contributed to economic growth both in the UK and internationally.
Summary
Scottish medical schools have delivered world-leading research with measurable benefits for patients, healthcare systems and society. Their work spans clinical innovation, public health, biotechnology and health informatics. The report demonstrates how academic research has translated into real-world improvements in diagnosis, treatment and prevention across a wide range of conditions.
Key findings
- Research from the University of Aberdeen led to the development of M&S’s ‘Fuller Longer’ food range and a new Alzheimer’s drug, and underpinned Scotland’s diabetic retinopathy screening programme.
- The University of Dundee pioneered biomedical informatics for diabetes care, developed BNP testing for heart failure, and identified the filaggrin gene as a major factor in eczema and allergy.
- The University of Edinburgh contributed to the development of the GRACE risk score for heart attacks, led the International Stroke Trial, and played a central role in cloning Dolly the sheep.
- The University of Glasgow’s research drove global adoption of statins, improved heart failure treatment, and demonstrated the health benefits of smoke-free legislation.
- The University of St Andrews developed interventions to reduce violence and created a psychological therapy for cancer patients with fear of recurrence.
Download this report
